Announcements Trials
Browse Landscape

Status

Unknown 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 216Observational 4Expanded_access 2

Sponsor

Cancer Type

Plasma cell 4

Conditions

Multiple Myeloma 4

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × carfilzomib × Clear all
NCT05620238 2025-08-21

Home Treatment With Carfilzomib in Patients With Multiple Myeloma

Odense University Hospital

Recruiting
12 enrolled
Plasma cell

Multiple Myeloma

NCT04458831 2025-06-27

IONA-MM

Sanofi

Active not recruiting
583 enrolled
Plasma cell

Multiple Myeloma

NCT05495620 2022-08-10

Long-term KRd in Relapsed and/or Refractory Multiple Myeloma

Dong-A University Hospital

Unknown
300 enrolled
Plasma cell

Multiple Myeloma

NCT04004338 2019-07-02

Carfilzomib in Combination for the Treatment of RR MM

Black Sea Hematology Association

Unknown
300 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡